Pfizer said its results topped expectations, although its revenue declined as the company continued to see pressure from losing exclusivity on some products.
from WSJ.com: US Business http://ift.tt/1Atu1ud
via IFTTT
from WSJ.com: US Business http://ift.tt/1Atu1ud
via IFTTT
No comments:
Post a Comment